Functional screening in Drosophila reveals the conserved role of REEP1 in promoting stress resistance and preventing the formation of Tau aggregates

Human Molecular Genetics

Volumn 23, Issue 25, 2014, Pages 6762-6772

  Appocher, Chiara ^a   Klima, Raffaella ^a   Feiguin, Fabian ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DROSOPHILA PROTEIN; EYE PROTEIN; PROTEIN AGGREGATE; REEP1 PROTEIN, DROSOPHILA; REEP1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TAU PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CYTOLOGY; DROSOPHILA MELANOGASTER; ENDOPLASMIC RETICULUM STRESS; EYE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HIGH THROUGHPUT SCREENING; METABOLISM; MICROTUBULE; MOLECULAR GENETICS; NERVE CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CONSERVED SEQUENCE; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; ENDOPLASMIC RETICULUM STRESS; EYE; EYE PROTEINS; GENE EXPRESSION REGULATION; GENOTYPE; HIGH-THROUGHPUT SCREENING ASSAYS; MEMBRANE TRANSPORT PROTEINS; MICROTUBULES; MOLECULAR SEQUENCE DATA; NEURONS; PHENOTYPE; PROTEIN AGGREGATES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 84929323830     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu393     Document Type: Article

References (56)

1. Shulman, J.M. and De Jager, P.L. (2009) Evidence for a common pathway linking neurodegenerative diseases. Nat. Genet., 41, 1261–1262.
2. Jucker, M. and Walker, L.C. (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature, 501, 45–51.
3. Guo, J.L. and Lee, V.M.Y. (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat. Med., 20, 130–138.
4. Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A. and Hof, P.R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev., 33, 95 – 130.
5. Kolarova, M., García-Sierra, F., Bartos, A., Ricny, J. and Ripova, D. (2012) Structure and pathology of tau protein in Alzheimer disease. Int. J. Alzheimers Dis., 2012, 731526.
6. Lei, P., Ayton, S., Finkelstein, D.I., Adlard, P.A., Masters, C.L. and Bush, A.I. (2010) Tau protein: relevance to Parkinson’s disease. Int. J. Biochem. Cell Biol., 42, 1775–1778.
7. Caparros-Lefebvre, D., Kerdraon, O., Devos, D., Dhaenens, C.M., Blum, D., Maurage, C.A., Delacourte, A. and Sablonnière, B. (2009) Association of corticobasal degeneration and Huntington’s disease: can Tau aggregates protect Huntingtin toxicity? Mov. Disord. Off. J. Mov. Disord. Soc., 24, 1089 – 1090.
8. Delacourte, A., Robitaille, Y., Sergeant, N., Buée, L., Hof, P.R., Wattez, A., Laroche-Cholette, A., Mathieu, J., Chagnon, P. and Gauvreau, D. (1996) Specific pathological Tau protein variants characterize Pick’s disease. J. Neuropathol. Exp. Neurol., 55, 159 – 168.
9. Arai, T., Ikeda, K., Akiyama, H., Shikamoto, Y., Tsuchiya, K., Yagishita, S., Beach, T., Rogers, J., Schwab, C. and McGeer, P.L. (2001) Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick’s disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol. (Berl.), 101, 167 – 173.
10. Houlden, H., Johnson, J., Gardner-Thorpe, C., Lashley, T., Hernandez, D., Worth, P., Singleton, A.B., Hilton, D.A., Holton, J., Revesz, T. et al. (2007) Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11. Nat. Genet., 39, 1434 – 1436.
11. McDermott, C.J., White, K., Bushby, K. and Shaw, P.J. (2000) Hereditary spastic paraparesis: a review of new developments. J. Neurol. Neurosurg. Psychiatry, 69, 150–160.
12. Wharton, S.B., McDermott, C.J., Grierson, A.J., Wood, J.D., Gelsthorpe, C., Ince, P.G. and Shaw, P.J. (2003) The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. J. Neuropathol. Exp. Neurol., 62, 1166 – 1177.
13. Tanuma, N., Miyata, R., Kumada, S., Kubota, M., Takanashi, J., Okumura, A., Hamano, S. and Hayashi, M. (2010) The axonal damage marker tau protein in the cerebrospinal fluid is increased in patients with acute encephalopathy with biphasic seizures and late reduced diffusion. Brain Dev., 32, 435–439.
14. McKee, A.C., Stern, R.A., Nowinski, C.J., Stein, T.D., Alvarez, V.E., Daneshvar, D.H., Lee, H.-S., Wojtowicz, S.M., Hall, G., Baugh, C.M. et al. (2013) The spectrum of disease in chronic traumatic encephalopathy. Brain J. Neurol., 136, 43 – 64.
15. Powers, J.M., Byrne, N.P., Ito, M., Takao, M., Yankopoulou, D., Spillantini, M.G. and Ghetti, B. (2003) A novel leukoencephalopathy associated with tau deposits primarily in white matter glia. Acta Neuropathol. (Berl.), 106, 181 – 187.
16. Brüggemann, N., Gottschalk, S., Körtke, D., Marxsen, J.H. and Moser, A. (2012) Excessively increased CSF tau in progressive multifocal leukoencephalopathy. Clin. Neurol. Neurosurg., 114, 762–764.
17. Ohm, T.G., Treiber-Held, S., Distl, R., Glöckner, F., Schönheit, B., Tamanai, M. and Meske, V. (2003) Cholesterol and tau protein – findings in Alzheimer’s and Niemann Pick C’s disease. Pharmacopsychiatry, 36 (Suppl 2), S120 – 731126.
18. Wolfe, M.S. (2012) The role of tau in neurodegenerative diseases and its potential as a therapeutic target. Scientifica, 2012, 1–20.
19. Züchner, S., Wang, G., Tran-Viet, K.-N., Nance, M.A., Gaskell, P.C., Vance, J.M., Ashley-Koch, A.E. and Pericak-Vance, M.A. (2006) Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am. J. Hum. Genet., 79, 365 – 369.
20. Beetz, C., Schüle, R., Deconinck, T., Tran-Viet, K.-N., Zhu, H., Kremer, B.P.H., Frints, S.G.M., van Zelst-Stams, W.A.G., Byrne, P., Otto, S. et al. (2008) REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain J. Neurol., 131, 1078–1086.
21. Hewamadduma, C., McDermott, C., Kirby, J., Grierson, A., Panayi, M., Dalton, A., Rajabally, Y. and Shaw, P. (2009) New pedigrees and novel mutation expand the phenotype of REEP1-associated hereditary spastic paraplegia (HSP). Neurogenetics, 10, 105–110.
22. Park, S.H., Zhu, P.-P., Parker, R.L. and Blackstone, C. (2010) Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network. J. Clin. Invest., 120, 1097–1110.
23. McCorquodale, D.S. 3rd, Ozomaro, U., Huang, J., Montenegro, G., Kushman, A., Citrigno, L., Price, J., Speziani, F., Pericak-Vance, M.A. and Züchner, S. (2011) Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia. Clin. Genet., 79, 523–530.
24. Beetz, C., Pieber, T.R., Hertel, N., Schabhüttl, M., Fischer, C., Trajanoski, S., Graf, E., Keiner, S., Kurth, I., Wieland, T. et al. (2012) Exome sequencing identifies a REEP1 mutation involved in distal hereditary motor neuropathy type V. Am. J. Hum. Genet., 91, 139 – 145.
25. Bernstein, E., Caudy, A.A., Hammond, S.M. and Hannon, G.J. (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature, 409, 363–366.
26. Dietzl, G., Chen, D., Schnorrer, F., Su, K.-C., Barinova, Y., Fellner, M., Gasser, B., Kinsey, K., Oppel, S., Scheiblauer, S. et al. (2007) A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature, 448, 151–156.
27. Beetz, C., Koch, N., Khundadze, M., Zimmer, G., Nietzsche, S., Hertel, N., Huebner, A.-K., Mumtaz, R., Schweizer, M., Dirren, E. et al. (2013) A spastic paraplegia mouse model reveals REEP1-dependent ER shaping. J. Clin. Invest., 123, 4273–4282.
28. Björk, S., Hurt, C.M., Ho, V.K. and Angelotti, T. (2013) REEPs are membrane shaping adapter proteins that modulate specific g protein-coupled receptor trafficking by affecting ER cargo capacity. PLoS ONE, 8, e76366.
29. Chigurupati, S., Wei, Z., Belal, C., Vandermey, M., Kyriazis, G.A., Arumugam, T.V. and Chan, S.L. (2009) The homocysteine-inducible endoplasmic reticulum stress protein counteracts calcium store depletion and induction of CCAAT enhancer-binding protein homologous protein in a neurotoxin model of parkinson disease. J. Biol. Chem., 284, 18323 – 18333.
30. Hetz, C. and Mollereau, B. (2014) Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci., 15, 233–249.
31. Hoozemans, J.J.M., Veerhuis, R., Haastert, E.S.V., Rozemuller, J.M., Baas, F., Eikelenboom, P. and Scheper, W. (2005) The unfolded protein response is activated in Alzheimer’s disease. Acta Neuropathol. (Berl.), 110, 165 – 172.
32. Loewen, C.A. and Feany, M.B. (2010) The unfolded protein response protects from tau neurotoxicity in vivo. PLoS ONE, 5, e13084.
33. Berrigan, D., Hercus, M., Dagher, H. and Hoffmann, A.A. (1997) Comparing different measures of heat resistance in selected lines of Drosophila melanogaster. J. Insect Physiol., 43, 393 – 405.
34. Girardot, F., Monnier, V. and Tricoire, H. (2004) Genome wide analysis of common and specific stress responses in adult drosophila melanogaster. BMC Genomics, 5, 74–90.
35. Huey, R.B., Crill, W.D., Kingsolver, J.G. and Weber, K.E. (1992) A method for rapid measurement of heat or cold resistance of small insects. Funct. Ecol., 6, 489.
36. Chan, C.-C., Scoggin, S., Wang, D., Cherry, S., Dembo, T., Greenberg, B., Jin, E.J., Kuey, C., Lopez, A., Mehta, S.Q. et al. (2011) Systematic discovery of Rab GTPases with synaptic functions in Drosophila. Curr. Biol., 21, 1704 – 1715.
37. Dricu, A., Carlberg, M., Wang, M. and Larsson, O. (1997) Inhibition of N-linked glycosylation using tunicamycin causes cell death in malignant cells: role of down-regulation of the insulin-like growth factor 1 receptor in induction of apoptosis. Cancer Res., 57, 543–548.
38. Harding, H.P., Zhang, Y. and Ron, D. (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature, 397, 271 – 274.
39. Bertolotti, A., Zhang, Y., Hendershot, L.M., Harding, H.P. and Ron, D. (2000) Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol., 2, 326–332.
40. Lai, E., Teodoro, T. and Volchuk, A. (2007) Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology, 22, 193–201.
41. Fulga, T.A., Elson-Schwab, I., Khurana, V., Steinhilb, M.L., Spires, T.L., Hyman, B.T. and Feany, M.B. (2007) Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat. Cell Biol., 9, 139 – 148.
42. Biernat, J., Mandelkow, E.M., Schroter, C., Lichtenberg-Kraag, B., Steiner, B., Berling, B., Meyer, H., Mercken, M., Vandermeeren, A. and Goedert, M. (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J., 11, 1593 – 1597.
43. Goedert, M., Jakes, R., Crowther, R.A., Cohen, P., Vanmechelen, E., Vandermeeren, M. and Cras, P. (1994) Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer’s disease: identification of phosphorylation sites in tau protein. Biochem. J., 301, 871 – 877.
44. Goedert, M., Jakes, R. and Vanmechelen, E. (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett., 189, 167 – 169.
45. Mercken, M., Vandermeeren, M., Lübke, U., Six, J., Boons, J., Van de Voorde, A., Martin, J.J. and Gheuens, J. (1992) Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol. (Berl.), 84, 265 – 272.
46. LoPresti, P., Szuchet, S., Papasozomenos, S.C., Zinkowski, R.P. and Binder, L.I. (1995) Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc. Natl. Acad. Sci., 92, 10369 – 10373.
47. Chen, C.-N., Chu, C.-C., Zentella, R., Pan, S.-M. and Ho, T.-H.D. (2002) AtHVA22 gene family in Arabidopsis: phylogenetic relationship, ABA and stress regulation, and tissue-specific expression. Plant Mol. Biol., 49, 633 – 644.
48. Guo, W.-J., Ho, T.-H. and David Ho, T.-H. (2008) An abscisic acid-induced protein, HVA22, inhibits gibberellin-mediated programmed cell death in cereal aleurone cells. Plant Physiol., 147, 1710 – 1722.
49. Calero, M., Whittaker, G.R. and Collins, R.N. (2001) Yop1p, the yeast homolog of the polyposis locus protein 1, interacts with Yip1p and negatively regulates cell growth. J. Biol. Chem., 276, 12100–12112.
50. Schaeffer, V., Lavenir, I., Ozcelik, S., Tolnay, M., Winkler, D.T. and Goedert, M. (2012) Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain J. Neurol., 135, 2169 – 2177.
51. Chesser, A.S., Pritchard, S.M. and Johnson, G.V.W. (2013) Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease. Front. Neurol., 4, 122 – 134.
52. Miura, S., Shibata, H., Kida, H., Noda, K., Toyama, T., Iwasaki, N., Iwaki, A., Ayabe, M., Aizawa, H., Taniwaki, T. et al. (2011) Partial SPAST and DPY30 deletions in a Japanese spastic paraplegia type 4 family. Neurogenetics, 12, 25–31.
53. Denton, K.R., Lei, L., Grenier, J., Rodionov, V., Blackstone, C. and Li, X.-J. (2014) Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia. Stem Cells, 32, 414 – 423.
54. Bland, M.L., Lee, R.J., Magallanes, J.M., Foskett, J.K. and Birnbaum, M.J. (2010) AMPK supports growth in Drosophila by regulating muscle activity and nutrient uptake in the gut. Dev. Biol., 344, 293–303.
55. Li, W.-Z., Li, S.-L., Zheng, H.Y., Zhang, S.-P. and Xue, L. (2012) A broad expression profile of the GMR-GAL4 driver in Drosophila melanogaster. Genet. Mol. Res., 11, 1997–2002.
56. Wu, J.S. and Luo, L. (2006) A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining. Nat. Protoc., 1, 2110–2115.